CC
GSK icon

Cultivar Capital’s GSK GSK Stock Holding History

Cultivar Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
6,309
+81
+1% +$4.28K 0.21% 25
2026
Q1 		$344K Hold
6,228
– – 0.22% 27
2025
Q4 		$305K Hold
6,228
– – 0.2% 30
2025
Q3 		$269K Hold
6,228
– – 0.18% 33
2025
Q2 		$239K Hold
6,228
– – 0.17% 33
2025
Q1 		$241K Hold
6,228
– – 0.19% 26
2024
Q4 		$211K Hold
6,228
– – 0.18% 27
2024
Q3 		$255K Hold
6,228
– – 0.21% 23
2024
Q2 		$240K Hold
6,228
– – 0.2% 25
2024
Q1 		$267K Hold
6,228
– – 0.23% 25
2023
Q4 		$231K Buy
+6,228
New +$224K 0.2% 26

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Cultivar Capital's GSK Position: Q2 2026 in Review

Cultivar Capital increased its GSK (GSK) stake by 1.3% in Q2 2026, buying an estimated $4.28K and bringing the position to 6,309 shares worth $331K. The position accounts for 0.21% of the portfolio, ranked #25.

Cultivar Capital first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $344K in Q1 2026. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Cultivar Capital held 6,309 shares of GSK worth $331K as of Q2 2026.
  • Cultivar Capital bought 81 GSK shares in Q2 2026, an estimated $4.28K.
  • GSK made up 0.21% of Cultivar Capital's portfolio in Q2 2026, its #25 holding.
  • Cultivar Capital first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • Cultivar Capital's GSK position peaked at $344K in Q1 2026.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cultivar Capital's 13F filing for Q2 2026, filed 8 Jul 2026.